Clearmind Medicine regains compliance with Nasdaq

* Clearmind Medicine (NASDAQ:CMND [https://seekingalpha.com/symbol/CMND]) announced [https://seekingalpha.com/pr/20337895-clearmind-medicine-successfully-regains-compliance-with-nasdaqs-minimum-stockholders-equity] on Friday that on December 10, 2025, the company  had regained compliance with Nasdaq Listing Rule 5550(b)(1), which requires listed companies to maintain at least $2.5M in stockholder's equity.
* Shares -37.27%.

MORE ON CLEARMIND MEDICINE INC.

* Clearmind Medicine announces receipt of Nasdaq minimum bid price notification [https://seekingalpha.com/news/4529097-clearmind-medicine-announces-receipt-of-nasdaq-minimum-bid-price-notification]
* Clearmind Medicine registers 17M shares for resale linked to $10M convertible note deal [https://seekingalpha.com/news/4496760-clearmind-medicine-registers-17m-shares-for-resale-linked-to-10m-convertible-note-deal]
* Seeking Alpha’s Quant Rating on Clearmind Medicine Inc. [https://seekingalpha.com/symbol/CMND/ratings/quant-ratings]
* Financial information for Clearmind Medicine Inc. [https://seekingalpha.com/symbol/CMND/income-statement]